Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorAndrew Catanzaro, Barney S. Graham, Gary J. Nabel et al.|The Journal of Infectious Diseases|2006Cited by 318
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trialJulie E. Martin, Barney S. Graham, Mark K. Louder et al.|Vaccine|2008Cited by 274
A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical TrialJulie E. Martin, Nancy J. Sullivan, Mary E. Enama et al.|Clinical and Vaccine Immunology|2006Cited by 236
Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate VaccineBarney S. Graham, Gary J. Nabel, Richard A. Koup et al.|The Journal of Infectious Diseases|2006Cited by 220
A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adultsJulie E. Ledgerwood, Barney S. Graham, Pamela Costner et al.|Vaccine|2010Cited by 211